NAV3 and COVID-19: Most recently, both SRRM4 and NAV3 were reported to be upregulated in the COVID-19 patients’ nasopharyngeal tissue, indicating yet to be discovered specific functional roles, especially during infectious diseases, and awaits investigating the functional role in a focused way.